**When the FDA Goes Shopping for Baby Formula**
1h ago · 2 sources · regulation
The FDA just wrapped what it calls its largest infant formula contaminant test ever, pulling more than 300 samples off shelves across the US. Inspectors bought products directly from grocery stores and online retailers, using 2023 retail sales data to guide the basket. The result, most samples showed very low or undetectable levels of contaminants like lead, arsenic and PFAS. No regulatory or enforcement actions were triggered.
The sweep falls under Operation Stork Speed and the agency’s Closer to Zero initiative, which aims to set action levels for contaminants including lead, arsenic, cadmium and mercury in foods for infants and children. So yes, oversight is active. But stakeholders pointed out gaps. The FDA did not publish numeric ranges for contaminants or rank them by priority.
Little Spoon’s CEO Ben Lewis called the effort a starting point, not a safety system. His pitch, mandatory pre-market batch testing with published results. Little Spoon already runs its own “Always Tested” standard, independently testing each batch across six categories before shipment and publishing results. The company says it uses voluntary standards based on European and global benchmarks rather than current FDA limits.
Why it matters, baby nutrition runs on trust. A one-time market basket survey offers reassurance, but it also highlights how much room there is between “no enforcement action” and “zero tolerance.” The brands that win may be the ones that treat transparency like a feature, not a footnote.
Key facts
- FDA released results from what it described as the largest infant formula contaminant testing it has conducted, examining more than 300 infant formula samples sold in the US, including domestically produced and imported products.
- FDA said most samples tested for contaminants such as lead, arsenic and PFAS revealed very low or undetectable concentrations and the testing did not trigger regulatory or enforcement actions.
- The testing is part of FDA oversight under Operation Stork Speed and its Closer to Zero initiative, which aims to establish action levels for contaminants including lead, arsenic, cadmium and mercury in foods for infants and children.
- FDA purchased infant formula products directly from retail locations, including grocery stores and online retailers, to provide a snapshot of products on shelves based on 2023 retail sales data.
- Little Spoon CEO Ben Lewis said a one-time market basket survey is a starting point, not a safety system, and called for mandatory pre-market batch testing with published results.
- Little Spoon operates under an internal 'Always Tested' standard, independently testing each infant formula batch across six categories before shipment and publishing the results publicly.
- Little Spoon tests its infant formula batches against voluntary standards based on European and global benchmarks rather than current FDA limits, and does not ship contaminated batches.
- Stakeholders noted that FDA testing did not include numeric ranges for contaminants or publicly rank contaminants by priority.
- more than 300 samples
- 2023 retail sales data
- six categories
Coverage
- Behind the scenes tour: From ingredients to the shelf
nutraingredients · 23h ago
- Seppic targets gut–brain axis with strawberry leaf ingredient
nutraingredients · 1d ago
- Horizon Organic plays down impact of multi-state milk recall
dairy_reporter · 1d ago
- FrieslandCampina invests €90M in whey protein for sports nutrition
nutraingredients · 4d ago
- Trend tracker: HMO innovations, social commerce strategies, sports nutrition
nutraingredients · 4d ago
- Canada update: Red tape reduction in the natural health products sector
nutraingredients · 6d ago
- FDA’s largest infant formula test yet finds ‘low’ contaminants – but no new rules
dairy_reporter · 6d ago